Prostate-specific membrane antigen positron emission tomography/computed tomography combined with sentinel node biopsy for primary lymph node staging in prostate cancer.

To determine the diagnostic capabilities of combined prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and sentinel node (SN) biopsy in PSMA PET/CT negative patients for the primary lymph node (LN) staging in prostate cancer (PCa) patients. Methods Between January 2017 and March 2019, retrospectively, all consecutive patients with primary diagnosed intermediate- or high-risk PCa who underwent a preoperative PSMA PET/CT (68Ga or 18F-DCFPyL) followed by robot-assisted radical prostatectomy and extended pelvic lymph node dissection (ePLND) were included. All patients without suspected LN metastases on PSMA PET/CT were considered candidates for SN biopsy with indocyanine green (ICG) -99mTc-nanocolloid or 99mTc-nanocolloid with free ICG as used tracers. The ePLND was used as reference standard. Results Of 53 patients, 22 had a positive PSMA PET/CT and 31 received subsequent SN biopsy after negative PSMA PET/CT. In total, 23 patients (43%) were pN1, of which 6 (26%) with a negative PSMA PET/CT and subsequent SN biopsy. The combined use of SN biopsy and PSMA PET/CT identified all pN1 patients (100% sensitivity, 95% Confidence Interval [CI] 86-100) and performed correct nodal staging in 50 of 53 patients (94% diagnostic accuracy, 95% CI 84-99). SN biopsy identified significantly smaller LN metastases (median diameter of 2.0 mm interquartile range [IQR] 1.0-3.8) than PSMA PET/CT (5.5 mm IQR 2.6-9.3; P = 0.007). Conclusion Combining both modalities led to a 94% accuracy for nodal staging in primary diagnosed intermediate- and high-risk PCa. Adding SN biopsy in patients with a negative PSMA PET/CT increases the combined sensitivity to 100% for detecting nodal metastases at ePLND. This diagnostic accuracy may provide valuable information for directing further treatment in PCa patients, such as PSMA PET/CT and SN biopsy rather than ePLND as preferred diagnostic approach for staging purposes of men prior to radiotherapy for PCa.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Sep 27 [Epub ahead of print]

Florentien J Hinsenveld, Esther M K Wit, Pim J van Leeuwen, Oscar R Brouwer, Maarten L Donswijk, Corinne N Tillier, Erik Vegt, Henricus A M van Muilekom, Matthijs N van Oosterom, Fijs W B van Leeuwen, Henk G van der Poel

the Netherlands Cancer Institute, Netherlands., the Netherlands Cancer Institute, Leiden University Medical Center, Netherlands., Leiden University Medical Center, Netherlands.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe